Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses?
about
Long-stay psychiatric patients: a prospective study revealing persistent antipsychotic-induced movement disorderMild expression differences of MECP2 influencing aggressive social behavior.Timing dysfunctions in schizophrenia as measured by a repetitive finger tapping task.Functional deficits in the extrastriate body area during observation of sports-related actions in schizophrenia.DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactomeOxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognitionCurrent perspectives on chlorpromazine equivalents: Comparing apples and oranges!Metabolic and inflammatory genes in schizophrenia.QTc and psychopharmacs: are there any differences between monotherapy and polytherapy.Frequency and Outcome of Neuroleptic Rotation in the Management of Delirium in Patients with Advanced Cancer.Effects of sports participation on psychiatric symptoms and brain activations during sports observation in schizophreniaAntipsychotic Prescribing Patterns in First-episode Schizophrenia: A Five-year ComparisonPredictive saccades are impaired in biological nonpsychotic siblings of schizophrenia patients.Dose Equivalents for Antipsychotic Drugs: The DDD MethodTreatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national studyEvaluation of Defined Daily Dose, percentage of British National Formulary maximum and chlorpromazine equivalents in antipsychotic drug utilizationEffect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial.No involvement of the adenosine A2A receptor in tardive dyskinesia in Russian psychiatric inpatients from Siberia.Parameter-based assessment of spatial and non-spatial attentional deficits in Huntington's disease.Physicians' reasons not to discontinue long-term used off-label antipsychotic drugs in people with intellectual disability.Atypical age-dependency of executive function and white matter microstructure in children and adolescents with autism spectrum disorders.Insular pathology in young people with high-functioning autism and first-episode psychosis.Cognitive remediation therapy (CRT) benefits more to patients with schizophrenia with low initial memory performances.Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison.Functional deterioration from the premorbid period to 2 years after the first episode of psychosis in early-onset psychosis.Memory-guided saccade abnormalities in schizophrenic patients and their healthy, full biological siblings.Attention and visual orienting in siblings, schizophrenic patients, and controls: impairment in attentional disengagement.Inflexible information acquisition strategies mediate visuo-spatial reasoning in stabilized schizophrenia patients.Theory of mind in adolescents with early-onset schizophrenia: correlations with clinical assessment and executive functions.
P2860
Q28477329-9CCBE68F-21E5-446C-A7C6-94F6635F6BAEQ30438103-30E9369D-BF6A-4DC0-BBA2-5A2306B9D5DCQ30478348-4579A4E5-4A9B-4326-8EE4-52C36AE34C2FQ33890082-0ACD5AC7-34EC-435E-9793-CD2CD39B79E3Q33894409-B167484B-BD1E-41FB-B29B-DA7C6279F4A9Q34270701-9BE1E08E-CCB9-4763-8C19-BFB59982421BQ34355429-3B37D0E0-8A1B-4FEE-9F19-437604599994Q34769260-5E4B28F5-14BA-40C0-8ED9-A181ADFF16F3Q35799717-C8E5F43D-348E-46A8-8AF8-7CD12A1D83C8Q35862286-B8E604A2-7005-41C7-8075-2BE6A22B538DQ35862424-1614E573-B4A7-4114-9127-DA0DD87E5FBBQ36325431-25362161-5731-4950-8390-02C0D941E5DDQ36345269-F6D3DA42-89F6-424B-9038-D772B4324F39Q37124935-9FD4AC5B-3C03-4836-9706-44B54E48CAAAQ37220015-B29CF396-2150-4309-9BB5-34065079C322Q37631471-E048581F-B38F-4782-92A2-669933B6FC09Q42603087-3A3416F9-4BCC-40D7-A0E5-1DCE0634CB9AQ45232895-76A47F4F-15A5-4A2E-92AB-02B215DA8029Q45300190-AA7917B9-F7C6-4D72-8B56-DE6CFA20EB37Q47708555-164E1BDD-383A-40DB-9E9C-2BC0685C8027Q47739088-B97CA00C-A2B5-4BEC-9104-2F3640F0F6B6Q47900299-DA1BEFB8-FA71-4FDF-B85E-E5AB85CF479AQ50628725-C2D7F71A-8D6C-4146-983B-EC80B821D12AQ50709810-DAC1852C-46F5-4303-8781-D3FB82141FCFQ50953838-AAE5AECA-A6D7-4285-A05B-C189FD0E2532Q51897775-B842B0A6-A66B-45E6-A309-AA03DD330956Q51926021-AD1FF9E7-1860-4BEF-82CD-1BD3E7D4720AQ52898635-BE8811AD-B9AF-483B-B4D1-E488082DD2C6Q53771030-95878374-30D7-41FC-8636-E2E3722532AB
P2860
Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses?
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Chlorpromazine equivalents ver ...... pare antipsychotic drug doses?
@ast
Chlorpromazine equivalents ver ...... pare antipsychotic drug doses?
@en
Chlorpromazine equivalents ver ...... pare antipsychotic drug doses?
@nl
type
label
Chlorpromazine equivalents ver ...... pare antipsychotic drug doses?
@ast
Chlorpromazine equivalents ver ...... pare antipsychotic drug doses?
@en
Chlorpromazine equivalents ver ...... pare antipsychotic drug doses?
@nl
prefLabel
Chlorpromazine equivalents ver ...... pare antipsychotic drug doses?
@ast
Chlorpromazine equivalents ver ...... pare antipsychotic drug doses?
@en
Chlorpromazine equivalents ver ...... pare antipsychotic drug doses?
@nl
P2093
P1476
Chlorpromazine equivalents ver ...... pare antipsychotic drug doses?
@en
P2093
Claudia A W Rijcken
Jacobus R B J Brouwers
Taco B M Monster
P304
P356
10.1097/01.JCP.0000096247.29231.3A
P407
P577
2003-12-01T00:00:00Z